Alice Lu

Brigham and Women's Hospital

Papers

1

Total Citations

113

H-Index

1

About

Alice Lu is a pioneering biochemist whose work has fundamentally advanced our understanding of Alzheimer’s disease pathology. Her primary research focuses on the molecular mechanisms of amyloid β-protein (Aβ) metabolism and the proteolytic enzymes that regulate its clearance in the brain. Lu’s most impactful contribution came with her landmark 2003 study, which introduced novel fluorescence- and fluorescence polarization-based assays for quantifying Aβ degradation kinetics. This work, cited over 113 times, provided researchers with robust, practical tools to study the detailed activity of Aβ-degrading proteases—enzymes now recognized as critical regulators of brain Aβ levels in both health and disease. By solving a longstanding methodological bottleneck, Lu’s assays enabled subsequent discoveries linking impaired Aβ clearance to Alzheimer’s onset. Her innovative approach to substrate design and kinetic analysis has been widely adopted, making her a key figure in the development of therapeutic strategies targeting Aβ accumulation. Lu’s research continues to illuminate the delicate balance of protein homeostasis in the aging brain.

Research Focus

Key Achievements

1
H-Index
1
Papers
113
Total Citations
113
Avg Citations/Paper
🏆 Most Cited Paper
Kinetics of Amyloid β-Protein Degradation Determined by Novel Fluorescence- and Fluorescence Polarization-based Assays
113 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Brigham and Women's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago